BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sabatino L, Pancione M, Votino C, Colangelo T, Lupo A, Novellino E, Lavecchia A, Colantuoni V. Emerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancer. World J Gastroenterol 2014; 20(23): 7137-7151 [PMID: 24966585 DOI: 10.3748/wjg.v20.i23.7137]
URL: https://www.wjgnet.com/1007-9327/full/v20/i23/7137.htm
Number Citing Articles
1
Zuzana Tylichová, Nicol Straková, Jan Vondráček, Alena Hyršlová Vaculová, Alois Kozubík, Jiřina Hofmanová. Activation of autophagy and PPARγ protect colon cancer cells against apoptosis induced by interactive effects of butyrate and DHA in a cell type-dependent manner: The role of cell differentiationThe Journal of Nutritional Biochemistry 2017; 39: 145 doi: 10.1016/j.jnutbio.2016.09.006
2
QIQIN JIANG, QIONGYU LI, HONGWEI CHEN, ALING SHEN, QIAOYAN CAI, JIUMAO LIN, JUN PENG. Scutellaria barbata D. Don inhibits growth and induces apoptosis by suppressing IL-6-inducible STAT3 pathway activation in human colorectal cancer cellsExperimental and Therapeutic Medicine 2015; 10(4): 1602 doi: 10.3892/etm.2015.2692
3
Myoung-Hee Kang, Hyunji Choi, Masanobu Oshima, Jae-Ho Cheong, Seokho Kim, Jung Hoon Lee, Young Soo Park, Hueng-Sik Choi, Mi-Na Kweon, Chan-Gi Pack, Ju-Seog Lee, Gordon B. Mills, Seung-Jae Myung, Yun-Yong Park. Estrogen-related receptor gamma functions as a tumor suppressor in gastric cancerNature Communications 2018; 9(1) doi: 10.1038/s41467-018-04244-2
4
Alexandre Vallée, Jean-Noël Vallée, Yves Lecarpentier. PPARγ agonists: potential treatment for autism spectrum disorder by inhibiting the canonical WNT/β-catenin pathwayMolecular Psychiatry 2019; 24(5): 643 doi: 10.1038/s41380-018-0131-4
5
Akhileshwar Namani, Jing Li, Xiu Jun Wang, Xiuwen Tang. A Review of Compounds for Prevention of Colorectal CancerCurrent Pharmacology Reports 2017; 3(5): 221 doi: 10.1007/s40495-017-0101-6
6
Hsiao-Yen Hsieh, Cheng-Huang Shen, Ru-Inn Lin, Yu-Min Feng, Shih-Yuan Huang, Yuan-Hung Wang, Shu-Fen Wu, Cheng-Da Hsu, Michael W.Y. Chan. Cyproheptadine exhibits antitumor activity in urothelial carcinoma cells by targeting GSK3β to suppress mTOR and β-catenin signaling pathwaysCancer Letters 2016; 370(1): 56 doi: 10.1016/j.canlet.2015.09.018
7
Valentina De Nunzio, Rossella Donghia, Pasqua L. Pesole, Sergio Coletta, Nicola Calò, Maria Notarnicola. Serum Cytokine and miRNA Levels Are Differently Expressed in Right- and Left-Sided Colon CancerJournal of Clinical Medicine 2023; 12(18): 5986 doi: 10.3390/jcm12185986
8
Maria Rita Milone, Biagio Pucci, Tommaso Colangelo, Rita Lombardi, Federica Iannelli, Vittorio Colantuoni, Lina Sabatino, Alfredo Budillon. Proteomic characterization of peroxisome proliferator‐activated receptor‐γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotypeMolecular Oncology 2016; 10(8): 1344 doi: 10.1016/j.molonc.2016.07.006
9
Yuka Sasaki, Tsubasa Ochiai, Masaya Takamura, Yukihiro Kondo, Chieko Yokoyama, Shuntaro Hara. Role of prostacyclin synthase in carcinogenesisProstaglandins & Other Lipid Mediators 2017; 133: 49 doi: 10.1016/j.prostaglandins.2017.05.001
10
Alexandre Vallée, Jean-Noël Vallée, Yves Lecarpentier. Metabolic reprogramming in atherosclerosis: Opposed interplay between the canonical WNT/β-catenin pathway and PPARγJournal of Molecular and Cellular Cardiology 2019; 133: 36 doi: 10.1016/j.yjmcc.2019.05.024
11
Yi Wei, Jiawei Yu, Xiaopeng Zhang, Jiao Mu, Jun Zhang, Wei Zeng, Bing Feng. ICAT acts as a Coactivator in Regulating PPARγ Transcriptional Activity in Mesangial CellsExperimental and Clinical Endocrinology & Diabetes 2021; 129(05): 365 doi: 10.1055/a-0879-1846
12
Diana Zurlo, Pamela Ziccardi, Carolina Votino, Tommaso Colangelo, Carmen Cerchia, Fabrizio Dal Piaz, Sabrina Dallavalle, Salvatore Moricca, Ettore Novellino, Antonio Lavecchia, Vittorio Colantuoni, Angelo Lupo. The antiproliferative and proapoptotic effects of cladosporols A and B are related to their different binding mode as PPARγ ligandsBiochemical Pharmacology 2016; 108: 22 doi: 10.1016/j.bcp.2016.03.007
13
Andre Luiz Prezotto Villa, Rogério Serafim Parra, Marley Ribeiro Feitosa, Hugo Parra de Camargo, Vanessa Foresto Machado, Daniela Pretti da Cunha Tirapelli, José Joaquim Ribeiro da Rocha, Omar Feres. PPARG expression in colorectal cancer and its association with staging and clinical evolutionActa Cirúrgica Brasileira 2020; 35(7) doi: 10.1590/s0102-865020200070000008
14
Luca Piemontese, Carmen Cerchia, Antonio Laghezza, Pamela Ziccardi, Sabina Sblano, Paolo Tortorella, Vito Iacobazzi, Vittoria Infantino, Paolo Convertini, Fabrizio Dal Piaz, Angelo Lupo, Vittorio Colantuoni, Antonio Lavecchia, Fulvio Loiodice. New diphenylmethane derivatives as peroxisome proliferator-activated receptor alpha/gamma dual agonists endowed with anti-proliferative effects and mitochondrial activityEuropean Journal of Medicinal Chemistry 2017; 127: 379 doi: 10.1016/j.ejmech.2016.12.047
15
Alexandre Vallée, Yves Lecarpentier. Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During CarcinogenesisFrontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00745
16
Rui Ke, Xinming Xie, Shaojun Li, Yilin Pan, Jian Wang, Xin Yan, Weijin Zang, Li Gao, Manxiang Li. 5-HT induces PPAR γ reduction and proliferation of pulmonary artery smooth muscle cells via modulating GSK-3β/β-catenin pathwayOncotarget 2017; 8(42): 72910 doi: 10.18632/oncotarget.20582
17
Saiprasad Gowrikumar, Rizwan Ahmad, Srijayaprakash Babu Uppada, Mary K. Washington, Chanjuan Shi, Amar B. Singh, Punita Dhawan. Upregulated claudin-1 expression promotes colitis-associated cancer by promoting β-catenin phosphorylation and activation in Notch/p-AKT-dependent mannerOncogene 2019; 38(26): 5321 doi: 10.1038/s41388-019-0795-5
18
Farzad Masoudkabir, Nizal Sarrafzadegan, Carolyn Gotay, Andrew Ignaszewski, Andrew D. Krahn, Margot K. Davis, Christopher Franco, Arya Mani. Cardiovascular disease and cancer: Evidence for shared disease pathways and pharmacologic preventionAtherosclerosis 2017; 263: 343 doi: 10.1016/j.atherosclerosis.2017.06.001
19
Weiwei Yang, Ning Ning, Xiaoming Jin. The lncRNA H19 Promotes Cell Proliferation by Competitively Binding to miR-200a and Derepressing β-Catenin Expression in Colorectal CancerBioMed Research International 2017; 2017: 1 doi: 10.1155/2017/2767484
20
Ji Tae Kim, Chang Li, Heidi L. Weiss, Yuning Zhou, Chunming Liu, Qingding Wang, B. Mark Evers. Regulation of Ketogenic Enzyme HMGCS2 by Wnt/β-catenin/PPARγ Pathway in Intestinal CellsCells 2019; 8(9): 1106 doi: 10.3390/cells8091106
21
Tatsuya Morinishi, Yasunori Tokuhara, Hiroyuki Ohsaki, Emi Ibuki, Kyuichi Kadota, Eiichiro Hirakawa. Activation and Expression of Peroxisome Proliferator-Activated Receptor Alpha Are Associated with Tumorigenesis in Colorectal CarcinomaPPAR Research 2019; 2019: 1 doi: 10.1155/2019/7486727
22
Rana A. Alaaeddine, Perihan A. Elzahhar, Ibrahim AlZaim, Wassim Abou-Kheir, Ahmed S.F. Belal, Ahmed F. El-Yazbi. The Emerging Role of COX-2, 15-LOX and PPARγ in Metabolic Diseases and Cancer: An Introduction to Novel Multi-target Directed Ligands (MTDLs)Current Medicinal Chemistry 2021; 28(11): 2260 doi: 10.2174/0929867327999200820173853
23
Alexandre Vallée, Jean-Noël Vallée, Rémy Guillevin, Yves Lecarpentier. Interactions Between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma on Neuroinflammation, Demyelination, and Remyelination in Multiple SclerosisCellular and Molecular Neurobiology 2018; 38(4): 783 doi: 10.1007/s10571-017-0550-9
24
Magdalena Szaryńska, Agata Olejniczak, Jarosław Kobiela, Piotr Spychalski, Zbigniew Kmieć. Therapeutic strategies against cancer stem cells in human colorectal cancer (Review)Oncology Letters 2017;  doi: 10.3892/ol.2017.7261
25
Elizabeth Hibler. Epigenetics and Colorectal Neoplasia: the Evidence for Physical Activity and Sedentary BehaviorCurrent Colorectal Cancer Reports 2015; 11(6): 388 doi: 10.1007/s11888-015-0296-z
26
Jeremy E. Davis, Darcie Hastings. Transcriptional Regulation of TCF/LEF and PPARγ by Daidzein and Genistein in 3T3-L1 PreadipocytesJournal of Medicinal Food 2018; 21(8): 761 doi: 10.1089/jmf.2017.0136
27
Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée. Interplay of Opposing Effects of the WNT/β-Catenin Pathway and PPARγ and Implications for SARS-CoV2 TreatmentFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.666693
28
Alexandre Vallée, Yves Lecarpentier, Rémy Guillevin, Jean-Noël Vallée. Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosisOncotarget 2017; 8(52): 90579 doi: 10.18632/oncotarget.21234
29
Chie Kurihara, Reiko Sakurai, Tsai-Der Chuang, Alan J. Waring, Frans J. Walther, Virender K. Rehan. Combination of pioglitazone, a PPARγ agonist, and synthetic surfactant B-YL prevents hyperoxia-induced lung injury in adult mice lung explantsPulmonary Pharmacology & Therapeutics 2023; 80: 102209 doi: 10.1016/j.pupt.2023.102209
30
Musa Yaghoubizadeh, Leila Pishkar, Gholam Basati. Evaluation of the Relationship between Peroxisome Proliferator Receptors (PPARα, PPARγ, and PPARδ) Expression and Carcinoembryonic Antigen (CEA) in Patients with Colorectal Cancerjournal of ilam university of medical sciences 2022; 30(3): 75 doi: 10.52547/sjimu.30.3.75
31
Bassem Refaat, Adel Galal El-Shemi, Osama Adnan Kensara, Amr Mohamed Mohamed, Shakir Idris, Jawwad Ahmad, Athar Khojah. Vitamin D3 enhances the tumouricidal effects of 5-Fluorouracil through multipathway mechanisms in azoxymethane rat model of colon cancerJournal of Experimental & Clinical Cancer Research 2015; 34(1) doi: 10.1186/s13046-015-0187-9
32
Emily Yun-Chia Chang, Yi-Cheng Chang, Chia-Tung Shun, Yu-Wen Tien, Shu-Huei Tsai, Siow-Wey Hee, Ing-Jung Chen, Lee-Ming Chuang, Ajay Pratap Singh. Inhibition of Prostaglandin Reductase 2, a Putative Oncogene Overexpressed in Human Pancreatic Adenocarcinoma, Induces Oxidative Stress-Mediated Cell Death Involving xCT and CTH Gene Expressions through 15-Keto-PGE2PLOS ONE 2016; 11(1): e0147390 doi: 10.1371/journal.pone.0147390
33
Antonio Lavecchia, Carmen Cerchia. Selective PPARγ Modulators for Type 2 Diabetes Treatment: How Far have We Come and What does the Future Hold?Future Medicinal Chemistry 2018; 10(7): 703 doi: 10.4155/fmc-2018-0021
34
Rossella Basilotta, Marika Lanza, Giovanna Casili, Giulia Chisari, Stefania Munao, Lorenzo Colarossi, Laura Cucinotta, Michela Campolo, Emanuela Esposito, Irene Paterniti. Potential Therapeutic Effects of PPAR Ligands in GlioblastomaCells 2022; 11(4): 621 doi: 10.3390/cells11040621
35
Alagesan Seetha, Halagowder Devaraj, Ganapasam Sudhandiran. Indomethacin and juglone inhibit inflammatory molecules to induce apoptosis in colon cancer cellsJournal of Biochemical and Molecular Toxicology 2020; 34(2) doi: 10.1002/jbt.22433
36
Alexandre Vallée, Yves Lecarpentier, Rémy Guillevin, Jean-Noël Vallée. PPARγ agonists: Potential treatments for exudative age-related macular degenerationLife Sciences 2017; 188: 123 doi: 10.1016/j.lfs.2017.09.008
37
Carolina De Almeida, Matteo Lulli, Vincenzo di Pilato, Nicola Schiavone, Edda Russo, Giulia Nannini, Simone Baldi, Rossella Borrelli, Gianluca Bartolucci, Marta Menicatti, Antonio Taddei, Maria Ringressi, Elena Niccolai, Domenico Prisco, Gian Rossolini, Amedeo Amedei. Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis’ Strains Isolated from Healthy Donors and Colorectal Cancer PatientsJournal of Clinical Medicine 2019; 8(3): 388 doi: 10.3390/jcm8030388
38
Leonardo Brunetti, Fulvio Loiodice, Luca Piemontese, Paolo Tortorella, Antonio Laghezza. New Approaches to Cancer Therapy: Combining Fatty Acid Amide Hydrolase (FAAH) Inhibition with Peroxisome Proliferator-Activated Receptors (PPARs) ActivationJournal of Medicinal Chemistry 2019; 62(24): 10995 doi: 10.1021/acs.jmedchem.9b00885
39
Xin Zhang, Bo Hu, Yun‐Fan Sun, Xiao‐Wu Huang, Jian‐Wen Cheng, Ao Huang, Hai‐Ying Zeng, Shuang‐Jian Qiu, Ya Cao, Jia Fan, Jian Zhou, Xin‐Rong Yang. Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF‐kB signaling pathways synergisticallyClinical and Translational Medicine 2021; 11(2) doi: 10.1002/ctm2.335